Surgical Robotics Technology
new generation surgical displays

10 Million Procedures Performed with Intuitive da Vinci Surgical Systems


Intuitive (Nasdaq: ISRG) has today announced that the number of robotic-assisted surgical procedures performed worldwide by surgeons using da Vinci surgical systems has surpassed 10 million.

“Surgeon use of da Vinci surgical systems in more than 10 million procedures reflects the benefits that high-quality, minimally invasive surgery conveys to patients, families, and the healthcare systems that care for them,” said Intuitive CEO Gary Guthart. “While we are proud of this milestone and momentum, this is really a moment to look at what we’ve learned from these 10 million procedures and ask ourselves how we can apply that to improving the field of surgery for years to come.”

Cleared for use by the U.S. Food & Drug Administration in 2000, there are more than 6,500 da Vinci surgical systems installed in 67 countries, and more than 55,000 surgeons worldwide have trained on the use of da Vinci systems.

“We have always sought to deliver solutions that meet our customers’ needs—better patient outcomes, better patient experiences, better care team experiences, and a lower total cost to treat per patient episode,” said Guthart. “We will continue to drive outcomes-focused innovation for our customers to help their patients for the next 10 million procedures and beyond.”

Intuitive plans to continue taking its deep and broad experience from these procedures and putting it to work for customers in the form of personalized surgical training programs, continued innovation in systems, instruments and accessories, and an expanded ecosystem of customer services, evidence development, and digital support and solutions.

There are nearly 70 representative clinical uses for da Vinci systems, spanning clinical specialties, including urology, gynecology, thoracic surgery, general surgery, and transoral surgery.

“The growing base of clinical evidence—nearly 30,000 studies on robotic-assisted surgery—and the increasing ability of surgeons, hospitals, and healthcare systems to assess their own data and patient outcomes, have been major drivers of surgeon adoption and the procedure growth that follows,” said Guthart. “Our customers are dedicated to the health and well-being of their patients—they don’t adopt and continue using technology that does not meet their needs.”

Intuitive’s latest, fourth generation of robotic systems, the da Vinci X, Xi, and its single-port system (SP), have continued to evolve through technology, as well as the addition of instruments, features, and digital support.

The company’s innovation in robotic-assisted technology includes development of its Ion endoluminal system designed to enable robotic-assisted lung biopsy.

Source: Intuitive.

Surgical Robotics Technology

Join thousands of Surgical Robotics Experts and get the latest updates straight to your inbox!